Loading
Total declarations
Company
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Jan 2026 for Nuvectis Pharma, Inc.. Read the official filing
Filing timeline
BuySaleShay Shemesh
Insider track record
Disclosed buys
12
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+10.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Shay Shemesh: trading record in brief
Shay Shemesh discloses dealings in Nuvectis Pharma, Inc. to SEC (Form 4). In total, 17 filings cover trades dated from 4 February 2022 to 6 January 2026.
On the market, this insider has only ever bought: 12 purchases, €53k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants.
The median purchase comes to €4,145. Clusters matter here: 12 out of 12 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 9 January 2026, the filings show a share grant in Nuvectis Pharma, Inc. The latest purchase dates back some time: it was published 888 days ago, on 13 May 2024. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Shay Shemesh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
150,000 shares0Common StockSEC:0001104659-26-002501:0
150,000 shares0Common StockSEC:0001104659-25-000913:0
1,113 shares@ US$6.3211.1% of flowCommon StockSEC:0001104659-24-060261:0
Canonical exit: 8 Aug 2024 (T+90)
130,000 shares0Common StockSEC:0001104659-24-001820:0
420 shares@ US$11.998.0% of flowCommon StockSEC:0001104659-23-035392:0
Canonical exit: 19 Jun 2023 (T+90)
670 shares@ US$10.7111.3% of flowCommon StockSEC:0001104659-23-033594:0
Canonical exit: 13 Jun 2023 (T+90)
115,000 shares0Common StockSEC:0001104659-23-003863:0
500 shares@ US$7.656.1% of flowCommon StockSEC:0001104659-22-129348:0
Canonical exit: 21 Mar 2023 (T+90)
150 shares@ US$7.101.7% of flowCommon StockSEC:0001104659-22-120080:0
Canonical exit: 14 Feb 2023 (T+90)
220 shares@ US$7.873.0% of flowCommon StockSEC:0001104659-22-103166:0
Canonical exit: 22 Dec 2022 (T+90)
404 shares@ US$8.315.7% of flowCommon StockSEC:0001104659-22-097692:0
Canonical exit: 1 Dec 2022 (T+90)
1,476 shares@ US$8.0720.1% of flowCommon StockSEC:0001104659-22-097216:0
Canonical exit: 29 Nov 2022 (T+90)
300 shares@ US$16.548.9% of flowCommon StockSEC:0001104659-22-063644:0
Canonical exit: 18 Aug 2022 (T+90)
100 shares@ US$19.283.5% of flowCommon StockSEC:0001104659-22-062271:0
Canonical exit: 14 Aug 2022 (T+90)
36 shares@ US$14.581.0% of flowCommon StockSEC:0001104659-22-059890:0
Canonical exit: 10 Aug 2022 (T+90)
60,000 shares0Common StockSEC:0001104659-22-042814:0
2,100 shares@ US$3.3811.8% of flowCommon Stock, par value $0.00001SEC:0001104659-22-014375:0
Canonical exit: 5 May 2022 (T+90)
17 of 17 declarations
